Vmbook Online ordering

Cardtronics Inc

**Company Information**

* **Name:** Catalent, Inc.

* **Symbol:** CATM

* **Exchange:** New York Stock Exchange (NYSE)

* **Industry:** Healthcare Services

* **Sector:** Pharmaceuticals, Biotechnology & Life Sciences

**Business Overview**

Catalent is a leading global provider of advanced delivery technologies, development, and manufacturing solutions for the pharmaceutical, biotech, and consumer health industries. The company offers a comprehensive range of services, including:

* Drug delivery technologies

* Clinical trial services

* Commercial manufacturing

* Packaging and labeling

* Supply chain management

**Financial Performance**

**Revenue:**

* 2022: $4.5 billion

* 2023 (Q1): $1.1 billion

**Earnings per Share (EPS):**

* 2022: $2.94

* 2023 (Q1): $0.70

**Growth:**

* Revenue growth: 13% in 2022

* EPS growth: 18% in 2022

**Key Metrics:**

* **Gross margin:** 32.5%

* **Operating margin:** 12.4%

* **Net income margin:** 7.6%

* **Return on equity (ROE):** 15.4%

**Analyst Ratings:**

* **Buy:** 10 analysts

* **Hold:** 5 analysts

* **Sell:** 1 analyst

**Recent News and Events:**

* **Q1 2023 Earnings:** The company reported strong financial results, with revenue and EPS exceeding analyst expectations.

* **Acquisition:** Catalent acquired Metrics Contract Services, a provider of clinical trial services, in February 2023.

* **Partnership:** The company announced a partnership with Moderna to manufacture and supply mRNA vaccines for the COVID-19 pandemic.

**Outlook:**

Catalent is well-positioned to benefit from the growing demand for outsourced pharmaceutical services. The company's strong financial performance, diverse customer base, and innovative technologies are expected to drive continued growth in the future.